1. About.com
  2. Health
  3. Weight Loss

FDA Reviewing Possible Orlistat-Liver Damage Connection

From Jennifer R. Scott, About.com Guide   September 8, 2009

The FDA has announced that it is reviewing safety information regarding orlistat users (available over-the-counter in the U.S. as Alli and by prescription as Xenical) and possible risk of liver damage.

According to the FDA: "Between 1999 and October 2008, 32 reports of serious liver injury, including 6 cases of liver failure, in patients using orlistat were submitted to FDA’s Adverse Event Reporting System. "

The FDA has not advised doctors change their prescribing practices with orlistat and say consumers currently taking Xenical should continue to take it as prescribed. Those using over-the-counter Alli should continue to use the product as directed as well.

However, the FDA says consumers should consult their doctor if they experience symptoms that could possibly be associated with the use of orlistat and development of liver injury, particularly weakness or fatigue, fever, jaundice or brown urine. Other symptoms may include abdominal pain, nausea, vomiting, light-colored stools, itching, or loss of appetite.

To report adverse affects you may visit the MedWatch Online Report provided by the FDA.

Related Reading: All About Alli

Comments
Comments are closed for this post.
Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>
Related Searches liver damage orlistat fda

©2012 About.com. All rights reserved. 

A part of The New York Times Company.

We comply with the HONcode standard
for trustworthy health
information: verify here.